CVS - CVS Health Corporation

NYSE - NYSE Delayed price. Currency in USD
73.59
-0.67 (-0.90%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous close74.26
Open74.22
Bid73.51 x 900
Ask74.00 x 1100
Day's range73.58 - 74.54
52-week range51.72 - 77.03
Volume3801102
Avg. volume6,802,063
Market cap96B
Beta (5Y Monthly)0.88
PE ratio (TTM)20.73
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield2.00 (2.69%)
Ex-dividend date2019-10-23
1y target estN/A
  • Target CEO: We are taking 'enormous' market share in cosmetics
    Yahoo Finance

    Target CEO: We are taking 'enormous' market share in cosmetics

    Target CEO Brian Cornell talks with Yahoo Finance about the company's success down the cosmetics aisle.

  • CVS Health Rides on Aetna Prospects, Strong Selling Season
    Zacks

    CVS Health Rides on Aetna Prospects, Strong Selling Season

    CVS Health's (CVS) 2020 PBM selling season is approaching closure and the 2021 selling season is ongoing.

  • The Zacks Analyst Blog Highlights: Toyota, CVS, 3M, Gilead and Goldman
    Zacks

    The Zacks Analyst Blog Highlights: Toyota, CVS, 3M, Gilead and Goldman

    The Zacks Analyst Blog Highlights: Toyota, CVS, 3M, Gilead and Goldman

  • Top Stock Reports for Toyota, CVS Health & 3M
    Zacks

    Top Stock Reports for Toyota, CVS Health & 3M

    Top Stock Reports for Toyota, CVS Health & 3M

  • UnitedHealth (UNH) to Buy Diplomat, Expand Pharmacy Services
    Zacks

    UnitedHealth (UNH) to Buy Diplomat, Expand Pharmacy Services

    UnitedHealth (UNH) inks an agreement to acquire Diplomat to expand its in-house pharmacy benefit management business.

  • Does CVS Health Corporation's (NYSE:CVS) P/E Ratio Signal A Buying Opportunity?
    Simply Wall St.

    Does CVS Health Corporation's (NYSE:CVS) P/E Ratio Signal A Buying Opportunity?

    This article is written for those who want to get better at using price to earnings ratios (P/E ratios). We'll look at...

  • Why Is CVS Health (CVS) Up 3.8% Since Last Earnings Report?
    Zacks

    Why Is CVS Health (CVS) Up 3.8% Since Last Earnings Report?

    CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • 20 businesses that died in the 2010s
    Yahoo Finance

    20 businesses that died in the 2010s

    Yahoo Finance takes a look back at some of the biggest corporate busts of the last decade.

  • Elizabeth Warren Wants to Spoil the Megamerger Party
    Bloomberg

    Elizabeth Warren Wants to Spoil the Megamerger Party

    (Bloomberg Opinion) -- The merger floodgates broke open five years ago, and now U.S. Senator Elizabeth Warren wants to close the hatch. Her proposed bill to substantially restrict big corporate tie-ups is more a presidential campaign statement than viable legislation — and it certainly won’t score her any more points with the Wall Street crowd — but she is calling attention to the maniacal pace of dealmaking in corporate America and the need to modernize antitrust laws that have permitted some recent problematic transactions.More than $7 trillion of takeovers of U.S. companies have been announced since this day in 2014 — 52,694 companies to be exact.(1) That compares with just $4.4 trillion of deals in the previous five-year period. The transactions grew over time as balance sheets flush with cash and income statements desperate for growth created a perfect storm, which more often than not was stoked by pliable regulators. The Walt Disney Co. acquired 21st Century Fox Inc.; Charter Communications Inc. bought Time Warner Cable Inc.; CVS Health Corp. took over Aetna Inc.; Marriott International Inc. merged with Starwood Hotels & Resorts Worldwide Inc.; and T-Mobile US Inc. is trying to buy Sprint Corp. Those are just some of the more recognizable names. Warren, one of the top-polling candidates heading into the Democratic primaries, wants to ban deals in which one company has annual revenue of more than $40 billion, or both businesses generate more than $15 billion in sales, according to a draft of the bill reviewed by Bloomberg News. (A notable exception would be companies facing insolvency.) That could effectively prevent every top airline, insurer, manufacturer, oil producer, retailer, technology platform and other conglomerates — perhaps even Warren Buffett’s M&A vehicle, Berkshire Hathaway Inc. — from making any acquisitions. It would sound the M&A death knell. The idea, however, is unlikely to gain broad support among lawmakers.Even so, it’s hard not to notice the rising drumbeat of politicians concerned about overreach by corporate giants, particularly those in the tech field. Senator Amy Klobuchar, another Democratic presidential candidate, plans to introduce separate antitrust legislation soon, Bloomberg News reported, citing a person familiar with the matter. (Michael Bloomberg, the founder and majority owner of Bloomberg LP, the parent of Bloomberg News and Bloomberg Opinion, is also campaigning for president.)For the Trump administration’s part, the U.S. Justice Department is already investigating whether tech giants — namely Apple Inc., Amazon.com Inc., Facebook Inc. and Google — are using their unchecked power to engage in harmful business practices. But as I wrote in July, if regulators are so concerned about protecting consumers from tech overreach, their glowing endorsement of T-Mobile’s takeover of Sprint is a funny way of showing it; it will shrink the U.S. wireless market from four to three major carriers and remove a company that’s helped to keep customer prices in check.Antitrust regulation under President Donald Trump has at times created questionable optics. Makan Delrahim, the Justice Department’s top antitrust enforcer, seemed to switch his stance on AT&T Inc.’s takeover of Time Warner Inc. as Trump railed against the deal. Time Warner was the parent of CNN, which Trump views as his personal nemesis. (I’ve argued that whatever the case, scrutiny of the megamerger was warranted considering the broad market power it gave to AT&T as media companies without such scale struggle to compete.) By comparison, Disney and Fox, which was controlled by Trump pal Rupert Murdoch, closed their megadeal with few regulatory hiccups. Warren has criticized other giant deals, such as the merger of SunTrust Banks Inc. and BB&T Corp. and the combination of seed makers Bayer AG and Monsanto Co. Given that they aren’t household names, though, most Americans are unfazed by or unaware of such deals, even though they may feel the effects later. Her bill would direct the government to take into account not just whether a merger will lead to higher prices but also what the impact might be on workers, privacy and industry innovation. To justify the cost of buying another large company, dealmakers tend to come up with ambitious estimates of synergies, a euphemism for layoffs. It’s clear that the meaning of “harm” needs to be expanded in the antitrust sense, and laws need to take a more holistic view of the potential consequences of M&A as the lines between industries continue to blur. The Big Tech factor also needs to be weighed, as some deals are being done in part to respond to companies like Amazon that are spreading their tentacles into new areas. On Wednesday, TV-network operators CBS Corp. and Viacom Inc. completed their own merger, a bid to cut costs and create more scale to compete against a new roster of even more powerful media giants: Amazon, Apple, AT&T and Disney. Even then, ViacomCBS Inc., as the merged entity is now called, may not be big enough, and so it may be only a matter of time before it gets swallowed. Warren’s overly broad proposal likely isn’t the answer. But Democrats do seem ready to at least try to rein in a market that’s gotten out of hand. For dealmakers, this may be last call at the M&A party.(1) Data compiled by Bloomberg as of Thursday morning. Excludes terminated deals.To contact the author of this story: Tara Lachapelle at tlachapelle@bloomberg.netTo contact the editor responsible for this story: Daniel Niemi at dniemi1@bloomberg.netThis column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Tara Lachapelle is a Bloomberg Opinion columnist covering the business of entertainment and telecommunications, as well as broader deals. She previously wrote an M&A column for Bloomberg News.For more articles like this, please visit us at bloomberg.com/opinion©2019 Bloomberg L.P.

  • Molina Healthcare Wins Kentucky Medicaid Managed Care Deal
    Zacks

    Molina Healthcare Wins Kentucky Medicaid Managed Care Deal

    Molina Healthcare's (MOH) Kentucky Medicaid Managed Care contract win to aid 2020 premium revenues.

  • Centene (CNC) Divests IlliniCare as Part of Merger Agreement
    Zacks

    Centene (CNC) Divests IlliniCare as Part of Merger Agreement

    Centene (CNC) inks a deal to divest IlliniCare to CVS Health to facilitate the pre-announced merger agreement.

  • CVS Health Set to Acquire Centene's IlliniCare Health Plan
    Zacks

    CVS Health Set to Acquire Centene's IlliniCare Health Plan

    CVS Health's (CVS) latest collaboration with Centene is set to expand its Medicaid and Medicare Advantage presence in Illinois.

  • CVS Gains After Report Activist Starboard Took Small Stake
    Bloomberg

    CVS Gains After Report Activist Starboard Took Small Stake

    (Bloomberg) -- Shares of CVS Health Corp. rose after a report that activist investment firm Starboard Value LP had taken a small stake in the drugstore chain and held talks with management.Shares of the company, which runs almost 10,000 drugstores across the U.S., closed up 1.7% Monday after the Wall Street Journal’s report.The Journal described the stake in CVS as small, and said the two firms had held amicable discussions. CVS declined to comment. Representatives for Starboard didn’t immediately respond to requests for comment.CVS, which has a market value of roughly $99.6 billion, would be a big target for Starboard. The New York hedge fund hasn’t shied away from mammoth targets though. Earlier this year, for example, it built a small position in Bristol-Myers Squibb Co. in a failed attempt to block its takeover of Celgene Corp.CVS has been transforming itself into a vertically integrated health-care company, with a pharmacy-benefit management unit and a health insurer, Aetna. It’s also transforming some of its stores into so-called health hubs, where people can get medical services.(Updates with CVS declining to comment in third paragraph)\--With assistance from Scott Deveau.To contact the reporter on this story: Robert Langreth in New York at rlangreth@bloomberg.netTo contact the editors responsible for this story: Drew Armstrong at darmstrong17@bloomberg.net, Timothy Annett, Mark SchoifetFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.

  • UPS expects to expand private home drone delivery by 2021
    Yahoo Finance

    UPS expects to expand private home drone delivery by 2021

    UPS has flown more than 1,000 revenue-generating drone delivery flights on medical campuses as it expands into private home delivery. the vice president of UPS advanced technology group discusses the next steps to make drone delivery mainstream.

  • 3 Healthcare Stocks to Counter Tech Encroachment
    Zacks

    3 Healthcare Stocks to Counter Tech Encroachment

    Traditional U.S. healthcare companies are resorting to vertical integration to counter the tech threat.

  • Should You Be Concerned About CVS Health Corporation's (NYSE:CVS) ROE?
    Simply Wall St.

    Should You Be Concerned About CVS Health Corporation's (NYSE:CVS) ROE?

    One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

  • The Extreme Risks of Trading Your Own Retirement Assets - November 15, 2019
    Zacks

    The Extreme Risks of Trading Your Own Retirement Assets - November 15, 2019

    From understanding your risk tolerance to maintaining emotional control, achieving your retirement goals takes a much different investing approach than regular stock trading.

  • 3 REITs for Dividend Investors to Buy with Stock Market at New Highs
    Zacks

    3 REITs for Dividend Investors to Buy with Stock Market at New Highs

    Here are three highly-ranked REITs we found using our Zacks Stock Screener that dividend investors might want to buy with stock indexes at new highs...

  • Here's Why You Should Hold on to CVS Health (CVS) For Now
    Zacks

    Here's Why You Should Hold on to CVS Health (CVS) For Now

    Investors can still hold on to CVS Health (CVS) stock, thanks to its solid prospects.

  • Walgreens Boots Rallies on KKR's Bid but Market View Mixed
    Zacks

    Walgreens Boots Rallies on KKR's Bid but Market View Mixed

    Albeit the market sentiment is bullish on Walgreens Boots' (WBA) potential acquisition deal, many analysts are in doubt about the company's effective approach to get privatized.

  • CVS Health's New Plans With Aetna May Improve Health Outcomes
    Zacks

    CVS Health's New Plans With Aetna May Improve Health Outcomes

    CVS Health's (CVS) Health Care Benefits segment develops Medicare program with Aetna.

  • Want To Retire Early? Learn the Intelligent Investing Secret - November 13, 2019
    Zacks

    Want To Retire Early? Learn the Intelligent Investing Secret - November 13, 2019

    Accomplishing the financial cushion to retire early is a fantasy for most, but bringing that fantasy to reality is not as difficult as it sounds. If you are willing to make some serious lifestyle adjustments, it can be achievable.

  • CVS Health's Aetna Prospects Solid, Omnicare Sluggish
    Zacks

    CVS Health's Aetna Prospects Solid, Omnicare Sluggish

    CVS Health's (CVS) strong Pharmacy Services segment sales gain traction from growth in specialty services.